STAT+: Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal

Rise and shine, another busy day is on the way. We can tell it is busy because our short person is hunched over a laptop and furiously taking notes, while our official mascot is bounding about the grounds and barking at chirping birds, a sure sign of spring, yes? As for us, we are hunched over the coffee kettle brewing another cup of stimulation. Our choice today is salted caramel mocha — an aromatic touch of the Jersey shore. Now, though, it is time to get cracking. So here are a few tidbits. Hope your journey progresses nicely today and please do stay safe — wear a mask …

The Covid-19 pandemic has forced the Food and Drug Administration to postpone hundreds of drug company inspections, creating an enormous backlog that is delaying new drug approvals and leading the industry to warn of impending shortages of existing medicines, The New York Times says. Pandemic-related travel restrictions and safety concerns have also hampered the ability to ensure the safety of the ever-increasing number of imported medicines, which make up more than 60% of the drugs sold in the U.S.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top